Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
These mechanisms represent potential therapeutic targets for CF treatment through modulation of post-translational modifications in the CFTR maturation pathway (Zaman et al., 2019)
J Parkinsons Dis 7:289299 Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, Rosati G (1996) Reduced intravenous glutathione in the treatment of early Parkinson's disease
The canonical structure has a quinolinium core with strategic substitutions that give it unique electronic and steric properties
Bacteriostatic water is correct for peptide reconstitution
Malignant Potential
H., & Satylganova, A
US$ 22.22
US$ 27.42
US$ 24.61
